allograft

同种异体移植物
  • 文章类型: Journal Article
    刚度的变化,固定方法,不同移植类型和前交叉韧带缝合修复(ACLSR)的前交叉韧带重建(ACLR)后的供体部位发病率可导致动态膝关节松弛的差异,并因此导致创伤后骨关节炎(PTOA)发展的差异。
    比较用于原发性ACLR的不同移植物类型之间以及原发性ACLR和ACLSR之间的PTOA发生率。据推测,PTOA的发生率在具有不同自体移植物和同种异体移植物的ACLR之间以及ACLR和ACLSR之间会有所不同。
    系统评价;证据水平,1.
    进行了文献搜索,以确定所有随机对照试验(RCT),比较了不同类型的移植物-绳肌腱(HT)自体移植物之间ACLR后PTOA的影像学证据,骨-髌腱-骨(BPTB)自体移植,股四头肌腱自体移植,和同种异体移植-以及ACLR和ACLSR之间。最少随访2年。使用改良的Coleman方法评分评估研究质量。进行荟萃分析以确定不同移植物类型之间以及ACLR和ACLSR之间的PTOA发生率是否存在差异。
    11项随机对照试验纳入荟萃分析-HT:440例患者(平均随访,9.7年);BPTB:307例患者(平均随访,11.8年);同种异体移植:246例患者(平均随访,5年);ACLSR,22例(5年)。未纳入报告股四头肌腱ACLR后发生率的研究。研究质量从70到88。荟萃分析表明,用于ACLR的移植物类型之间以及ACLR和ACLSR之间的PTOA发生率没有显着差异(风险比:HTvsBPTB,1.05;HT与同种异体移植物,0.81;BPTB与同种异体移植物,0.82;HT与ACLSR,不可估计的[全部P>.05])。在每种移植物类型的所有研究中,患有PTOA的患者的合并数量表明,接受BPTB自体移植物的ACLR患者的PTOA百分比最高(HT,23.4%;BPTB,29.6%;同种异体移植,8.1%;ACLSR,0%)。然而,排除随访<5年的研究,对于接受HT自体移植和BPTB自体移植的患者,结果相似.
    这项荟萃分析报告,用于ACLR的移植物类型之间以及ACLR和ACLSR之间的PTOA发生率没有差异。需要更多的研究才能得出可靠的结论,即哪种技术与ACL手术后的PTOA发生率最低有关。
    UNASSIGNED: Variation in stiffness, fixation methods, and donor-site morbidity after anterior cruciate ligament reconstruction (ACLR) with different graft types and with anterior cruciate ligament suture repair (ACLSR) can lead to differences in dynamic knee laxity and consequent differences in posttraumatic osteoarthritis (PTOA) development.
    UNASSIGNED: To compare the incidence of PTOA between different graft types used for primary ACLR and between primary ACLR and ACLSR. It was hypothesized that the incidence of PTOA would vary between ACLR with different autografts and allografts and between ACLR and ACLSR.
    UNASSIGNED: Systematic review; Level of evidence, 1.
    UNASSIGNED: A search of the literature was performed to identify all randomized controlled trials (RCTs) comparing radiographic evidence of PTOA after ACLR between different graft types-hamstring tendon (HT) autograft, bone-patellar tendon-bone (BPTB) autograft, quadriceps tendon autograft, and allograft-and between ACLR and ACLSR. The minimum follow-up was 2 years. Study quality was assessed using the modified Coleman Methodology Score. A meta-analysis was performed to determine whether there was a difference in the incidence of PTOA between the different graft types and between ACLR and ACLSR.
    UNASSIGNED: Eleven randomized controlled trials were included in the meta-analysis-HT: 440 patients (mean follow-up, 9.7 years); BPTB: 307 patients (mean follow-up, 11.8 years); allograft: 246 patients (mean follow-up, 5 years); ACLSR, 22 patients (5 years). No study reporting the incidence after ACLR with quadriceps tendon was included. The study quality ranged from 70 to 88. The meta-analysis indicated no significant difference in the incidence of PTOA between graft types used for ACLR and between ACLR and ACLSR (risk ratios: HT vs BPTB, 1.05; HT vs allograft, 0.81; BPTB vs allograft, 0.82; HT vs ACLSR, not estimable [P > .05 for all]). The combined number of patients with PTOA in all studies per graft type showed that patients who underwent ACLR with a BPTB autograft had the highest percentage of PTOA (HT, 23.4%; BPTB, 29.6%; allograft, 8.1%; ACLSR, 0%). However, excluding studies with a follow-up <5 years resulted in similar outcomes for patients with an HT autograft and a BPTB autograft.
    UNASSIGNED: This meta-analysis reported no difference in the incidence of PTOA between graft types used for ACLR and between ACLR and ACLSR. More research is necessary to make a reliable conclusion about which technique is associated with the lowest incidence of PTOA after ACL surgery.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    这项研究介绍了一名40岁的男性患者在肾移植后的情况。CT扫描显示下腹部和骨盆有一个大肿块,右髂外动脉的分支与生长相交。经过全面检查,研究表明,肿块来自移植的肾脏,并进行了根治性肾切除术(包括肿块)。我们记录了一例发生在移植肾中的非典型血管平滑肌脂肪瘤(AAM)。本文报道了该病例的研究,并对其临床表现进行了简要的文献综述,AAM的诊断和治疗。
    This study presents the case of a 40-year-old male patient after renal transplantation. The CT scan revealed a large mass in the lower abdomen and pelvis, with a branch of the right external iliac artery intersecting the growth. After a comprehensive examination, it was shown that the mass originated from the transplanted kidney, and a radical nephrectomy (including the mass) was performed. We document a case of atypical angiomyolipoma (AAM) occurring in a transplanted kidney. This article reports the case study and a brief literature review of the clinical presentation, diagnosis and treatment of AAM.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:颈椎前路椎间盘切除融合术(ACDF)后骨不连和明显下沉与不良的临床结局有关,偶尔会导致翻修手术。同种异体移植物和聚醚醚酮(PEEK)笼是用于ACDF的两种最常用的椎体间间隔装置。尽管已经进行了研究来比较这两种椎体间材料的功效,问题仍然是关于一个比另一个优越。因此,作者进行了系统评价和荟萃分析,以比较骨不连,沉降,使用同种异体移植物和PEEK笼作为体间设备的ACDF后的再手术率。
    方法:在本系统综述和荟萃分析中,作者系统地搜索了MEDLINE,EMBASE,和CochraneLibrary数据库,用于2023年11月之前发表的研究,比较了同种异体移植物和PEEK笼对ACDF的疗效和安全性。汇总分析旨在确定骨不连的差异,沉降,以及两个体间设备之间的再手术率。
    结果:涉及1462例患者的十项研究(同种异体移植,852名患者;PEEK笼,610名患者)被包括在内。汇总分析表明,与PEEK笼相比,同种异体移植的骨不愈合率显着降低(OR0.33,95%CI0.14-0.79;p=0.01)。此外,PEEK笼与同种异体移植相比,由于骨不连引起的再手术率明显更高(OR0.28,95%CI0.11-0.71;p<0.01),而由于整体原因导致的再手术率没有显着结果(OR0.38,95%CI0.11-1.29;p=0.12)。显著沉降的发生率(OR0.66,95%CI0.28-1.55;p=0.34)和平均沉降量(标准平均差0.03,95%CI-0.42至0.47;p=0.90)在同种异体移植和PEEK笼之间没有显着差异。
    结论:总体而言,目前的荟萃分析表明,同种异体移植优于用于ACDF的PEEK笼,由于提高了融合率和最小化的修订风险,没有增加沉降的风险。
    OBJECTIVE: Nonunion and significant subsidence after anterior cervical discectomy and fusion (ACDF) are associated with poor clinical outcomes, which occasionally lead to revision surgery. Allograft and polyetheretherketone (PEEK) cages are the two most commonly used interbody spacer devices for ACDF. Although studies have been conducted to compare the efficacies of these two interbody materials, the question remains regarding the superiority of one over the other. Therefore, the authors conducted a systematic review and meta-analysis to compare nonunion, subsidence, and reoperation rates after ACDF using allograft and PEEK cages as interbody devices.
    METHODS: In this systematic review and meta-analysis, the authors systematically searched the MEDLINE, EMBASE, and Cochrane Library databases for studies published prior to November 2023 that compared the efficacy and safety of allograft and PEEK cages for ACDF. A pooled analysis was designed to identify differences in nonunion, subsidence, and reoperation rates between the two interbody devices.
    RESULTS: Ten studies involving 1462 patients (allograft, 852 patients; PEEK cage, 610 patients) were included. The pooled analysis demonstrated that allograft had a significantly lower rate of nonunion compared to that of PEEK cages (OR 0.33, 95% CI 0.14-0.79; p = 0.01). Furthermore, the reoperation rate due to nonunion was significantly higher with PEEK cages compared to that with allograft (OR 0.28, 95% CI 0.11-0.71; p < 0.01), whereas the reoperation rate due to overall causes did not display significant results (OR 0.38, 95% CI 0.11-1.29; p = 0.12). The incidence of significant subsidence (OR 0.66, 95% CI 0.28-1.55; p = 0.34) and the mean amount of subsidence (standard mean difference 0.03, 95% CI -0.42 to 0.47; p = 0.90) did not demonstrate significant differences between allograft and PEEK cages.
    CONCLUSIONS: Overall, the current meta-analysis suggests the advantages of allograft over PEEK cages used for ACDF, due to an enhanced fusion rate and minimized revision risk, with no increase in the risk of subsidence.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在后外侧角(PLC)重建中存在几种手术技术和移植物类型的方法。文献缺乏有关PLC损伤的自体移植与同种异体移植重建后结果的知识。
    全面回顾目前关于PLC重建的文献,并比较自体移植和同种异体移植组织的结果。
    系统评价;证据水平,4.
    搜索PubMed和Scopus在线数据库时使用术语“PLC,膝关节后外侧,“后外侧角”,\"和\"重建\"在不同的组合。患者特征,移植物类型,移植失败,外科技术,功能结果评分,回顾了应力X线片上的内翻松弛度,并比较了自体移植物和同种异体移植物的PLC重建。
    包括22项研究,包括33个队列:16个自体移植物(n=280个膝盖)和17个同种异体移植物(336个膝盖)。有69个分离的PLC重建(58个同种异体移植物和11个自体移植物)和493个多韧带重建(269个自体移植物和224个同种异体移植物)。患者平均年龄没有差异(30.5岁vs33.5岁,分别为;P=.11)或平均随访时间(39.5vs37.7个月,分别;P=0.68)在自体移植组和同种异体移植组之间。没有证据表明移植物类型之间的移植物失败存在差异(自体移植物与同种异体移植物的合并平均值:0.44对0.41失败;P=.95)。自体移植物与同种异体移植物的术后Lysholm平均评分有显著差异(分别为89.6vs85.5;P=.04)。两组在术前或术后国际膝关节文献委员会(IKDC)评分或术后内翻松弛度方面没有差异。
    我们的综述和荟萃分析表明,仅基于移植物类型的PLC重建后,移植物失败率或客观结果没有显着差异。术后Lysholm评分与自体移植组有显著差异,IKDC主观评分无显著差异。
    UNASSIGNED: Several approaches to surgical techniques and graft types exist in posterolateral corner (PLC) reconstruction. The literature lacks knowledge regarding outcomes after autograft versus allograft reconstruction for PLC injuries.
    UNASSIGNED: To comprehensively review the current literature on PLC reconstruction and compare outcomes between autograft and allograft tissues.
    UNASSIGNED: Systematic review; Level of evidence, 4.
    UNASSIGNED: The PubMed and Scopus online databases were searched with the terms \"PLC,\"\"posterolateral knee,\"\"posterolateral corner,\" and \"reconstruction\" in varying combinations. Patient characteristics, graft type, graft failure, surgical techniques, functional outcome scores, and varus laxity on stress radiographs were reviewed and compared between PLC reconstruction with autografts versus allografts.
    UNASSIGNED: Included were 22 studies comprising 33 cohorts: 16 autografts (n = 280 knees) and 17 allografts (336 knees). There were 69 isolated PLC reconstructions (58 allografts and 11 autografts) and 493 multiligament reconstructions (269 autografts and 224 allografts). There was no difference in the mean patient age (30.5 vs 33.5 years, respectively; P = .11) or mean follow-up (39.5 vs 37.7 months, respectively; P = .68) between the autograft and allograft groups. There was no evidence to suggest a difference in graft failures between graft types (pooled mean autograft vs allograft: 0.44 vs 0.41 failures; P = .95). There was a significant difference in the mean postoperative Lysholm scores for autografts versus allografts (89.6 vs 85.5, respectively; P = .04). There was no difference between the cohorts in preoperative or postoperative International Knee Documentation Committee (IKDC) scores or postoperative varus laxity.
    UNASSIGNED: Our review and meta-analysis indicated no significant differences in graft failure rates or objective outcomes after PLC reconstruction based on graft type alone. There was a significant difference in postoperative Lysholm scores in favor of the autograft group and no significant difference in IKDC subjective scores.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    动脉瘤性骨囊肿(ABC)是骨骼系统的良性溶解性骨肿瘤,但未知来源的局部破坏性病变。它通常发生在儿童时期,通常涉及长骨的干phy端区域;因此,它在跟骨中的定位仍然很少见;在我们的案例中,它的非典型表现使其引人注目。
    方法:我们描述了一个患有慢性足跟痛的年轻患者,临床检查发现触诊时肿胀和疼痛。进行了完整的放射学评估,显示跟骨内有孤立性和扩张性溶骨性病变。治疗包括肿瘤刮治和同种异体移植和骨水泥重建。活检报告与ABC一致。术后18个月的随访具有良好的放射临床演变和无复发。
    ABCs是良性囊性扩张性肿瘤,具有反应性,局部破坏性和充满血液的,它们在跟骨发生的报告病例仅占总报告病例的1.6%。Talalgia是与肿胀相关的最常见体征。MRI上的液位图像是这些病变的病理标志,但金标准诊断仍然是组织学。他们的治疗是基于刮治-通过移植填充。
    结论:刮治联合移植使效果良好,并提高了生活质量。
    UNASSIGNED: Aneurysmal bone cyst (ABC) is a benign lytic bone tumor of the skeletal system but locally destructive lesion of unknown origin. It often occurs in childhood and usually involves the metaphyseal region of long bones; thus, its localisation in the calcaneum remains rare; its atypical presentation in our case makes it remarkable.
    METHODS: We describe a case of a young patient who suffered from chronic heel pain, in whom the clinical examination finds swelling and pain on palpation. A complete radiological assessment was carried out, which revealed a solitary and expansive osteolytic lesion within the calcaneus. Treatment included tumor curettage and reconstruction with allograft and cement. The biopsy report was consistent with an ABC. The postoperative follow-up at 18 months was marked by a good radio-clinical evolution and no recurrence.
    UNASSIGNED: ABCs are benign cystic expansive tumors that are reactive, locally destructive and blood-filled, their occurrence in the calcaneus has been reported in only 1.6 % of total reported cases. Talalgia is the most frequent sign associated with swelling. Liquid-liquid level images on MRI is a pathognomonic sign of these lesions but the gold standard diagnosis remains histology. Their treatment is based on curettage - filling by grafting.
    CONCLUSIONS: Curettage combined graft makes results butter and improves the quality of life.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    与重返运动相比,前十字韧带(ACL)重建(ACLR)后重返工作(RTW)的时机是一个研究较少的里程碑。
    系统评价ACLR后RTW的发生率和术后时机。
    系统评价;证据水平,4.
    这项研究是根据2020PRISMA(系统审查和荟萃分析的首选报告项目)声明进行的。在PubMed中进行了文献检索,Embase,科克伦,以及用于报告ACLR后RTW的临床研究的Ovid数据库,2022年8月确定了806项研究。使用非随机研究方法学指数(MINORS)分级系统进行质量评估。从研究中提取以下数据:研究特征,队列人口统计,ACLR技术,伴随半月板和/或软骨手术,术前患者报告的结果,RTW的比率,以及ACLR后RTW所需的天数。
    共有13项研究符合纳入标准,总计1791名患者(86.4%为男性)。在评估研究的方法学质量中观察到广泛的差异(MINORS评分范围,8-17).76.8%的人使用了绳肌腱(HT)自体移植(n=1377;平均年龄,30.5岁),同种异体移植物占17.1%(n=308;平均年龄,33.1岁),韧带高级加固系统占2.5%(n=46;平均年龄,33.2岁),骨-髌腱-自体骨移植占2%(n=36;平均年龄,28.5岁),股四头肌腱自体移植占1.3%(n=24;平均年龄,24.1岁)。在纳入的患者中,99.1%(n=1781)报告术后RTW成功。RTW的平均时间为84.2天(范围,31.4-107.1天),适用于HT和69.5天(范围,49-56.6天)用于同种异体移植。
    虽然没有关于ACL损伤前后工作强度的数据,我们的研究结果表明,患者最常发生RTW在手术后90天内.同种异体移植物ACLR患者可能比接受HT自体移植物ACLR患者更早发生RTW。
    UNASSIGNED: The timing of return to work (RTW) after anterior cruciate ligament (ACL) reconstruction (ACLR) is a less studied milestone compared with return to sports.
    UNASSIGNED: To systematically review the rate and postoperative timing of RTW after ACLR.
    UNASSIGNED: Systematic review; Level of evidence, 4.
    UNASSIGNED: This study was conducted in accordance with the 2020 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. A literature search was performed in PubMed, Embase, Cochrane, and Ovid databases for clinical studies reporting RTW after ACLR, and 806 studies were identified in August 2022. A quality assessment was performed using the Methodological Index of Nonrandomized Studies (MINORS) grading system. The following data were extracted from studies: study characteristics, cohort demographics, ACLR technique, concomitant meniscal and/or cartilage procedures, preoperative patient-reported outcomes, rates of RTW, and days required for RTW after ACLR.
    UNASSIGNED: A total of 13 studies met inclusion criteria, totaling 1791 patients (86.4% male). Wide variability was observed in the methodological quality of the assessed studies (MINORS score range, 8-17). Hamstring tendon (HT) autograft was used in 76.8% (n = 1377; mean age, 30.5 years old), allograft in 17.1% (n = 308; mean age, 33.1 years old), the ligament advanced reinforcement system in 2.5% (n = 46; mean age, 33.2 years old), bone-patellar tendon-bone autograft in 2% (n = 36; mean age, 28.5 years old), and quadriceps tendon autograft in 1.3% (n = 24; mean age, 24.1 years old). Among the included patients, 99.1% (n = 1781) reported successful RTW after surgery. The mean time to RTW was 84.2 days (range, 31.4-107.1 days) for HT and 69.5 days (range, 49-56.6 days) for allograft.
    UNASSIGNED: While data regarding work intensity before and after ACL injury were absent, our study results suggested that patients most often RTW within 90 days of surgery. Patients with allograft ACLR may RTW earlier than patients undergoing ACLR with HT autograft.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Systematic Review
    目的:椎体间在腰椎关节固定术中的作用没有得到充分的证据支持,影响临床决策和偶尔的保险范围。这项研究旨在比较退行性脊柱疾病患者使用合成椎间垫片(cage)与单纯结构性骨移植(自体移植或同种异体移植)的腰椎关节固定术之间的临床和放射学结果。
    方法:对文献进行了系统综述,以确定直接比较使用和不使用椎间固定架的腰椎椎间关节固定术结果的研究。使用随机效应模型在荟萃分析中综合了各个研究的结果。
    结果:纳入了20项研究,涉及1508例患者(769例使用椎间融合器,739例没有椎间融合器)。椎间融合器的放置与手术后椎间盘高度的增加有关(4.0mmvs3.4mm,p<0.01)。在使用椎间笼子的情况下,背痛的减少(视觉模拟量表[VAS]评分)显着增加(5.4vs4.7,p=0.03)。笼组的融合率高5.5%(96.3%vs90.8%),具有统计学意义(p=0.03)。两组全因再手术率无统计学差异,并发症发生率,或改善Oswestry残疾指数评分或腿部疼痛(VAS评分)。
    结论:这些结果表明植入椎间融合器与更高的融合率相关,更有效地维护光盘高度,和更大的改善背痛。这项研究强调了腰椎关节固定术中椎间融合器对退行性脊柱疾病患者的临床价值。
    OBJECTIVE: The role of interbodies in lumbar arthrodesis has been insufficiently supported by evidence, impacting clinical decision-making and occasionally insurance coverage. This study aimed to compare clinical and radiological outcomes between lumbar arthrodesis with a synthetic interbody spacer (cage) versus structural bone graft alone (autograft or allograft) in patients with degenerative spine disease.
    METHODS: A systematic review of the literature was performed to identify studies directly comparing outcomes of lumbar interbody arthrodesis with and without interbody cage use. The outcomes of individual studies were synthesized in meta-analyses using random-effects models.
    RESULTS: Twenty studies with 1508 patients (769 with an interbody cage and 739 without an interbody cage) were included. Interbody cage placement was associated with a significantly greater increase in disc height after surgery (4.0 mm vs 3.4 mm, p < 0.01). There was a significantly greater reduction of back pain (visual analog scale [VAS] score) in cases in which an interbody cage was used (5.4 vs 4.7, p = 0.03). Fusion rates were 5.5% higher in the cage group (96.3% vs 90.8%) and reached statistical significance (p = 0.03). No statistically significant differences were identified between the two groups regarding all-cause reoperation rates, complication rates, or improvement in Oswestry Disability Index score or leg pain (VAS score).
    CONCLUSIONS: These results suggest that implantation of an interbody cage is associated with higher rates of fusion, more effective maintenance of disc height, and greater improvement of back pain. This study underlines the clinical value of interbody cages in lumbar arthrodesis for patients with degenerative spine disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:使用适当的动物模型进行癌症研究是一项重大挑战,特别是对于缺乏维持和使用异种移植动物或基因工程小鼠模型(GEMM)资源的研究人员。此外,几个打算纳入这些模式的国家必须进行进口程序,带来了额外的挑战。
    目的:这篇综述旨在探索在有限资源下使用细胞来源的同种异体移植或同基因模型。结果可供调查人员使用,特别是来自中低收入国家,有助于肺癌根除。
    方法:在各种数据库上进行了文献检索,包括PubMed,WebofScience,还有Scopus.此外,选定文章的出版年份设置在2013年至2023年之间,具有不同的搜索组件(SC),即肺癌(SC1),动物模型(SC2),和临床前研究(SC3)。
    结果:本系统综述集中于选择动物,细胞,和可用于产生同种异体移植型肺癌动物模型的方法来自101篇文章。
    结论:根据结果,在癌症研究中使用细胞来源的同种异体移植模型是可行和相关的,它提供了有关资源有限的条件的宝贵见解。
    BACKGROUND: The use of appropriate animal models for cancer studies is a major challenge, particularly for investigators who lack the resources to maintain and use xenograft animals or genetically engineered mouse models (GEMM). In addition, several countries intending to incorporate these models must conduct importation procedures, posing an additional challenge.
    OBJECTIVE: This review aimed to explore the use of cell-derived allograft or syngeneic models under limited resources. The results can be used by investigators, specifically from low-middle-income countries, to contribute to lung cancer eradication.
    METHODS: A literature search was carried out on various databases, including PubMed, Web of Science, and Scopus. In addition, the publication year of the selected articles was set between 2013 and 2023 with different search components (SC), namely lung cancer (SC1), animal models (SC2), and preclinical studies (SC3).
    RESULTS: This systematic review focused on selecting animals, cells, and methods that could be applied to generating allograft-type lung cancer animal models from 101 included articles.
    CONCLUSIONS: Based on the results, the use of cell-derived allograft models in cancer studies is feasible and relevant, and it provides valuable insights regarding the conditions with limited resources.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    (1)背景:本研究的目的是描述所有可能的外科手术程序,打算治疗后肩关节脱位的McLaughlin病变(或反向Hill-Sachs)。(2)方法:谷歌学者,Pubmed,和Embase在我们的研究中被用作数据库。评估了报告通过手术治疗肱骨病变的后肩脱位结果的研究。排除报告骨折脱位和多向不稳定性后结果的研究。(3)结果:共有16项研究纳入我们的审查,共207个肩膀,平均年龄为41.7岁,平均评估时间为62.1个月。改良的McLaughlin程序和移植程序是最常见的。在临床评分的评估中,两者之间没有发现统计学上的显着差异。(4)结论:我们的审查强调了根据外科医生的经验和患者的特征进行正确诊断和准确选择手术治疗的重要性。
    (1) Background: The aim of this study is to describe all of the possible surgical procedures that intend to treat the McLaughlin lesion (or Reverse Hill-Sachs) in posterior shoulder dislocation. (2) Methods: Google Scholar, Pubmed, and Embase were used as databases in our research. Studies reporting the results of posterior shoulder dislocations surgically treated with procedures addressing the humeral lesion were evaluated. The studies reporting results after fracture-dislocation and multidirectional instability were excluded. (3) Results: A total of 16 studies were included in our review for a total of 207 shoulders with a mean age of 41.7 years that were evaluated at a mean of 62.1 months. The Modified McLaughlin procedure and the Graft procedures were the most commonly performed. No statistically significant difference was found between the two at the evaluation of the clinical score. (4) Conclusions: Our review highlights the importance of a correct diagnosis and an accurate surgical treatment choice based on the surgeon\'s experience and on the patients\' characteristics.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    慢性腰痛是全球残疾和医疗保健支出的主要原因。椎间盘源性疼痛,源自椎间盘的疼痛,是慢性下背痛的常见病因。目前,接受的慢性椎间盘源性疼痛的治疗仅集中在症状的管理,如疼痛。没有批准的治疗方法可以阻止或逆转椎间盘的退化。已经开发了促进椎间盘再生的生物疗法以扩展治疗选择。VIADISC™NP,是一种可行的椎间盘同种异体移植补充剂,在最近的一次审判中,在患有症状性椎间盘退行性疾病的患者中,疼痛显着减轻,功能增强。
    这篇手稿总结了下腰痛的流行病学和病因学,椎间盘退行性疾病的病理生理学,目前的治疗方法,需要更新的疗法。还讨论了椎间盘内生物制剂治疗症状性椎间盘退行性疾病的基本原理。
    导致椎间盘退变的生物学特征允许椎间盘内生物制剂的发展。它们可能很快就能够预防和逆转椎间盘退变。临床试验显示出了希望,但在这些疗法被广泛应用之前,还需要进一步研究疗效和安全性。
    UNASSIGNED: Chronic lower back pain is a leading cause of disability and healthcare spending worldwide. Discogenic pain, pain originating from the intervertebral disk, is a common etiology of chronic lower back pain. Currently, accepted treatments for chronic discogenic pain focus only on the management of symptoms, such as pain. There are no approved treatments that stop or reverse degenerating intervertebral discs. Biologic therapies promoting disc regeneration have been developed to expand treatment options. VIADISC™ NP, is a viable disc allograft supplementation that, in a recent trial, demonstrated a significant reduction in pain and increased function in patients suffering from symptomatic degenerative disc disease.
    UNASSIGNED: This manuscript summarizes the epidemiology and etiology of low back pain, the pathophysiology of degenerative disc disease, current treatments, and a need for newer therapies. The rationale behind intradiscal biologics for the treatment of symptomatic degenerative disc disease is also discussed.
    UNASSIGNED: Characterization of the biology leading to disc degeneration has allowed for the development of intradiscal biologics. They may soon be capable of preventing and reversing disc degeneration. Clinical trials have shown promise, but further research into efficacy and safety is needed before these therapies are widely employed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号